Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-311-4 | CAS number: 8002-50-4 Extractives and their physically modified derivatives such as proteins, carbohydrates, lipids, nucleic acids, inorganic ions, etc. obtained from Brevoortia tyrannis.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Tests of the genotoxicity of several oils produced from algae or yeast which consist of fatty acids also present in menhaden oil are negative in all cases. Therefore, menhaden oil is expected to be not genotoxic, as well.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods
- Qualifier:
- according to guideline
- Guideline:
- other: FDA Redbook 2000, IV.C.1.a Bacterial Reverse Mutation Test
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- The source of the EPA oil used in these studies was a biotechnology-derived Y. lipolytica yeast. The EPA oil was extracted from the yeast and processed under Good Manufacturing Practice (GMP; food, 21 CFR110) standards at Pilot Plant Corporation (POS), Saskatoon, Saskatchewan, Canada. The EPA oil contained residual antioxidants (e.g., approximately 300 ppm tocopherols).
- Species / strain / cell type:
- S. typhimurium TA 1535
- Species / strain / cell type:
- S. typhimurium TA 1537
- Species / strain / cell type:
- S. typhimurium TA 98
- Species / strain / cell type:
- S. typhimurium TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- 10% S9
- Test concentrations with justification for top dose:
- 1.5, 5.0, 15, 50, 150, 500, 1500 and 5000 µg per plate. Top dose choice was based on an initialtoxicity test. This dose was achieved using a concentration of 100 mg/mL EPA oil and a 50 lL plating aliquot.
- Vehicle / solvent:
- DMSO
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 2-nitrofluorene
- sodium azide
- other: 2-Aminoanthracene, Acridine mutagen ICR-191
- Details on test system and experimental conditions:
- EPA oil was evaluated for mutagenicity in the Ames assay using the plate incorporation method. The study was conducted as two trials. DMSO was chosen as the dosing vehicle based on the solubility of the test substance and compatibility with the target cells. Appropriate positive controls were included in the study. Revertant colonies were counted with an automated counter (Sorcerer, Perceptive Instruments Ltd., Suffold, United Kingdom).
- Evaluation criteria:
- Data were judged positive if the increase in mean revertants at the highest numerical dose response was >=2.0-fold, the mean concurrent negative control value (vehicle control) for strains TA98, TA100, and WP2uvrA, and >=3.0-fold for strains TA1535 and TA1537.
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- 2-Nitrofluorene at 1 µg/plate.
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- 2-Aminoanthracene at 2.5 µg/plate
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- Sodium azide at 2 µg/plate.
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- 2-Aminoanthracene at 2 µg/plate
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- Sodium azide at 2 µg/plate
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- 2-Aminoanthracene at 2.5 µg/plate
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- Acridine mutagen ICR-191 at 2 µg/plate
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- 2-Aminoanthracene at 2.5 µg/plate
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- 4-Nitroquinole-N-oxide at 1 µg/plate
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- 2-Aminoanthracene at 25 µg/plate
- Additional information on results:
- EPA oil did not increase the number of revertants in any of the tester strains used in the Ames assay when compared to the concurrent negative controls either in the absence or presence of S9, and tested to dose levels up to 5000 µg/plate. No appreciable toxicity was observed, but test substance precipitation was seen at 1500 or 5000 µg per plate.
- Conclusions:
- The oil was not mutagenic in the in vitro Ames assay.
- Executive summary:
In this publication by Belcher et al. 2011 the safety of an oil produced from yeast is evaluated which contains a high amount of polyunsaturated fatty acids. An Ames test is used to investigate the genotoxicity of this oil. Five test strains were used in the experiments and each assay was conducted with and without metabolic activation. The results of all tests are negative. The validity of the experiments was demonstrated by positive reactions induced by reference mutagens.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- DHA-algal oil is a refined food grade oil that is derived from Ulkenia sp. SAM2179, a thraustochytrid microalgae. It is manufactured through a multi-step fermentation process and a standard edible oil refining method. DHA-algal oil contains approximately 45% (w/w) of docosahexaenoic acid (DHA), as well as smaller amounts of palmitic acid (~35%) and docosapentaenoic acid (DPA) (~11%). The polyunsaturated fatty acids identified in DHA-algal oil are similar to those in fish oils.
- Species / strain / cell type:
- S. typhimurium TA 1535
- Species / strain / cell type:
- S. typhimurium TA 1537
- Species / strain / cell type:
- S. typhimurium TA 98
- Species / strain / cell type:
- S. typhimurium TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 fraction from the livers of Aroclor-induced rats
- Test concentrations with justification for top dose:
- 0.062, 0.185, 0.556,1.667, and 5 mg DHA-algal oil/plate
- Vehicle / solvent:
- DMSO/Water
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- benzo(a)pyrene
- ethylnitrosurea
- other: 2-aminoanthracene
- Details on test system and experimental conditions:
- Just before use, the test substance was suspended in dimethylsulfoxide (DMSO) vehicle at 50 mg/ml, warmed to 37 °C and mixed by shaking for 1 h. This suspension was used to prepare serial dilutions in water. The test substance suspension (0.1 ml), 0.1 ml of fully grown bacterial culture and 0.5 ml S9-mix or 0.5 ml of 100 mM sodium phosphate (pH 7.5) were added to 2 ml molten top agar (containing 0.6% agar, 0.5% sodium chloride and 0.05 mM L-histidine*HCl/0.05 mM biotin for the S. typhimurium strains and supplemented with 0.05 mM tryptophan for the E. coli strain) maintained at 46 °C. The ingredients were thoroughly mixed and immediately poured onto minimal glucose agar plates (1.5% agar in Vogel and Bonner medium E with 2% glucose). Following incubation at 37 °C for 3 days, the number of his+ and trp+ revertants were counted. The test sample was assayed in triplicate at five concentrations. Negative (solvent) and positive control experiments were also conducted.
- Evaluation criteria:
- If a twofold or greater increase in the mean number of revertants was observed compared to the number of revertants on negative control plates, the test substance was considered to be mutagenic.
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- In the second experiment, DHA-algal oil did not cause a twofold or greater increase in the mean number of revertant colonies compared to the background spontaneous reversion rate observed with the negative control. There was no evidence of a dose–response relationship. The mean number of revertant colonies of the negative controls was within the acceptable range, and the positive control mutagens gave the expected increase in the mean number of revertant colonies. The test substance was not toxic to any strain tested, as evidenced by the absence of a decrease in the mean number of revertant colonies.
- Conclusions:
- The test substance was not toxic to any strain tested.
- Executive summary:
In this publication by Blum et al. 2007 the genotoxicity and subchronic toxicity of an algal oil which contains a high amount of polyunsaturated fatty acids is evaluated. An Ames test is used to investigate the genotoxicity of this oil. Five test strains were used in the experiments and each assay was conducted with and without metabolic activation. The results of all tests are negative. The validity of the experiments was demonstrated by positive reactions induced by reference mutagens.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- Algal Oil from Schizochytrium sp. Algal Oil (Lot No. 98–5814E)
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- up to 5000 µg/plate
- Positive controls:
- yes
- Positive control substance:
- not specified
- Details on test system and experimental conditions:
- In the Ames test, Algal Oil was investigated for its potential to induce gene mutations according to the plate incorporation test using Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and tester strain Escherichia coli WP2 uvrA. In two independent experiments several concentrations up to 5000 µg/plate of the test item were used. Each assay was conducted with and without metabolic activation (S9 mix).
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Conclusions:
- In the Ames test, no toxic effects of the test item were noted in any of the five tester strains. The reference mutagens induced a distinct increase of revertant colonies as indication of the validity of the experiments.
- Executive summary:
In this publication by Fedorova-Dahms et al. 2011 the safety of an algal oil containing a high amount of polyunsaturated fatty acids is evaluated. The genotoxicity of this oil is investigated using an Ames test with five different test strains. Each assay was conducted with and without metabolic activation. Concentrations up to 5000 µg/plate were used. The results of all tests are negative.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- The material tested was DHA-rich Algal Oil from Schizochytrium sp. DHA-rich Algal Oil (lot # 9800005999) contained 43% Docosahexaenoic acid (DHA) and 8% Eicosapentaenoic acid (EPA) of total fatty acids in triglyceride form.
- Species / strain / cell type:
- S. typhimurium TA 1535
- Species / strain / cell type:
- S. typhimurium TA 1537
- Species / strain / cell type:
- S. typhimurium TA 98
- Species / strain / cell type:
- S. typhimurium TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- Several concentrations up to 5000 µl/plate of the test item
- Positive controls:
- yes
- Positive control substance:
- not specified
- Details on test system and experimental conditions:
- In the Ames test, DHA-rich Algal Oil was investigated for its potential to induce gene mutations according to the plate incorporation test using Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and tester strain Escherichia coli WP2 uvrA. Several concentrations up to 5000 µg/plate of the test item were used in two independent experiments. Each assay was conducted with and without metabolic activation (S9 mix).
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Conclusions:
- In the Ames test, no toxic effects of DHA-rich Algal Oil were noted in any of the five tester strains. No biologically relevant increases in revertant colony numbers were observed following treatment with DHA-rich Algal Oil at any concentration level, neither in the presence nor absence of metabolic activation. The reference mutagens induced a distinct increase of revertant colonies and demonstrated the validity of the experiments.
- Executive summary:
In this publication by Fedorova-Dahms et al. 2011 the safety of an algal oil rich in polyunsaturated fatty acids is evaluated. An Ames test is used to investigate the genotoxicity of this oil. Five test strains were used in the experiments and each assay was conducted with and without metabolic activation. The results of all genotoxicity tests are negative. The validity of the experiments was demonstrated by positive reactions induced by reference mutagens.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- ONC T-18 DHA-rich algal oil (lots no. 22630 and 22740; approximately 39–42% docosahexaenoic acid (DHA); total omega-3 fatty acids, approximately 41–44%; storage condition, frozen, -10 to -30 °C) was produced and received from Ocean Nutrition Canada Limited, Dartmouth, Nova Scotia, Canada. Ascorbyl palmitate and mixed natural tocopherols were added to the algal oil to prevent oxidation.
- Species / strain / cell type:
- S. typhimurium TA 1535
- Species / strain / cell type:
- S. typhimurium TA 1537
- Species / strain / cell type:
- S. typhimurium TA 98
- Species / strain / cell type:
- S. typhimurium TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- 313, 625, 1250, 2500, 5000 µg/plate. Choice of concentrations based on an initial dose range-finding assay.
- Vehicle / solvent:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 2-nitrofluorene
- sodium azide
- benzo(a)pyrene
- other: ICR-191, 2-aminoanthracene
- Details on test system and experimental conditions:
- DHA-rich algal oil was tested in a plate incorporation assay and an independent confirmatory assay performed under identical conditions. In the plate incorporation method, molten agar was utilized as the medium for transference of the test and control articles, metabolic activation system, and the bacterial culture to the agar plate, allowing colony growth. Three test plates per strain per treatment condition were used. Appropriate vehicle and positive controls were tested with each strain. Treatments were performed by adding 100 µL tester strain and 50 µL of test or control article to 2.5 mL of molten selective top agar (maintained at 45 ± 2 °C). After the required components had been added, the mixture was vortexed and overlaid onto the surface of 25 mL minimal bottom agar in a 15 x 100 mm petri dish. After the overlay solidified, the plates were inverted and incubated for 52 ± 4 h at 37 ± 2 °C. Cultures were treated in the presence of S9 in an identical manner, except using 2.0 mL undiluted molten selective top agar and adding 500 µL S9 mix.
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Remarks:
- 2-nitrofluorene
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Remarks:
- benzo(a)pyrene
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Remarks:
- sodium azide
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Remarks:
- 2-aminoanthracene
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Remarks:
- sodium azide
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Remarks:
- 2-aminoanthracene
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Remarks:
- ICR-191
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Remarks:
- 2-aminoanthracene
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Remarks:
- 4-nitroquinoline-N-oxide
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Positive controls validity:
- valid
- Remarks:
- 2-aminoanthracene
- Additional information on results:
- The results of the bacterial reverse mutation test with a confirmatory assay (Ames assay) indicate that under the conditions of the study, DHA-rich algal oil did not cause an increase in the number of histidine revertants (Salmonella strains) or tryptophan revertants (E. coli) per plate in the presence or absence of S9 microsomal enzymes. The positive control chemicals produced the expected increase in mutation frequency, and all criteria for a valid study were met.
- Conclusions:
- DHA-rich algal oil does not possess genotoxic potential under the conditions of the study.
- Executive summary:
In this publication by Schmitt et al. 2012 some toxicological properties of an algal oil which contains a high amount of docosahexaenoic acid (DHA) are evaluated. An Ames test is used to investigate the genotoxicity of this oil. Five test strains were used in the experiments and each assay was conducted with and without metabolic activation. The results of all tests are negative. The validity of the experiments was demonstrated by positive reactions induced by reference mutagens.
Referenceopen allclose all
Dose (µg/plate) | TA98 | TA100 | TA1535 | TA1537 | WP2uvrA |
Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |
DMSO-S9 | 18 ± 3 | 142 ± 19 | 11 ± 3 | 14 ± 4 | 22 ± 1 |
+S9 | 19 ± 9 | 109 ± 16 | 13 ± 3 | 10 ± 3 | 29 ± 0 |
Positive-S9 | 261 ± 65 | 593 ± 59 | 455 ± 28 | 1176 ± 71 | 207 ± 15 |
Control + S9 | 700 ± 533 | 438 ± 13 | 98 ± 25 | 54 ± 20 | 242 ± 38 |
50-S9 | 16 ± 3 | 144 ± 12 | 10 ± 5 | 10 ± 2 | 22 ± 3 |
+S9 | 31 ± 2 | 118 ± 9 | 14 ± 4 | 9 ± 6 | 23 ± 4 |
150-S9 | 16 ± 3 | 134 ± 7 | 13 ± 2 | 13 ± 5 | 23 ± 4 |
+S9 | 22 ± 5 | 120 ± 6 | 12 ± 1 | 10 ± 3 | 31 ± 2 |
500-S9 | 18 ± 1 | 149 ± 7 | 15 ± 3 | 10 ± 2 | 22 ± 1 |
+S9 | 23 ± 7 | 111 ± 2 | 11 ± 2 | 9 ± 3 | 26 ± 6 |
1500-S9 | 23 ± 3 | 137 ± 10 | 15 ± 1 | 10 ± 3 | 25 ± 3 |
+S9 | 26 ± 7 | 107 ± 25 | 12 ± 1 | 8 ± 6 | 23 ± 6 |
5000-S9 | 17 ± 4 | 138 ± 28 | 16 ± 5 | 11 ± 4 | 21 ± 3 |
+S9 | 26 ± 3 | 120 ± 20 | 11 ± 3 | 12 ± 3 | 25 ± 1 |
Dose (µg/pl) | Number of revertants (number of colonies/plate) | |||||||||
T A1535 | TA1537 | TA98 | TA100 | E. coli | ||||||
-S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | |
0 | 24 ± 2 | 18 ± 1 | 18 ± 5 | 19 ± 9 | 23 ± 4 | 45 ± 14 | 154 ± 12 | 145 ± 4 | 26 ± 3 | 31 ± 4 |
62 | 21 ± 5 | 27 ± 7 | 18 ± 1 | 18 ± 1 | 27 ± 3 | 34 ± 8 | 145 ± 12 | 157 ± 11 | 25 ± 5 | 28 ± 6 |
185 | 20 ± 5 | 15 ± 2 | 12 ± 7 | 14 ± 2 | 28 ± 10 | 37 ± 11 | 150 ± 14 | 148 ± 6 | 23 ± 5 | 31 ± 8 |
556 | 18 ± 6 | 26 ± 6 | 13 ± 5 | 16 ± 6 | 19 ± 9 | 50 ± 3 | 124 ± 37 | 136 ± 18 | 23 ± 12 | 29 ± 8 |
1667 | 22 ± 6 | 24 ± 6 | 15 ± 2 | 16 ± 3 | 25 ± 4 | 46 ± 9 | 132 ± 14 | 147 ± 9 | 23 ± 7 | 25 ±6 |
5000 | 29 ± 6 | 30 ± 2 | 13 ± 7 | 13 ± 2 | 21 ± 9 | 38 ± 7 | 120 ± 11 | 160 ± 10 | 30 ± 6 | 28 ± 2 |
Positive control | 473 ± 82 | 370 ± 42 | 1114 ± 167 | 268 ± 13 | 1008 ± 106 | 652 ± 123 | 533 ± 21 | 1509 ± 59 | 196 ± 10 | 464 ± 12 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
Tests of the genotoxicity of several oils produced from algae or yeast which consist of fatty acids also present in menhaden oil are negative in all cases. Therefore, menhaden oil is expected to be not genotoxic, as well.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
